Age, fibrosis, immune suppression link to less COVID vaccine response

Age, fibrosis, immune suppression link to less COVID vaccine response

A study from Israel, where vaccination for COVID reached most of the population older than 16 years, showed older patients, post-transplant patients and those with advanced liver disease produced less immune response to the Pfizer COVID-19 vaccine.“We had the chance to vaccinate until now almost 96% of the adult population who were 16 and above and just a week ago, we started to vaccinate the young people between the ages of 12 years and 16 years,” Rifaat Safadi, MD, director of the liver institute at the Hadassah-Hebrew University Hospital in Israel, said during a pressRead More

Share on facebook
Share on twitter
Share on linkedin